Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

(2022) Yusha Araf et al.   JOURNAL OF MEDICAL VIROLOGY

Cold sensitivity of the SARS-CoV-2 spike ectodomain

(2021) Robert J. Edwards et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

SARS-CoV-2 variants and ending the COVID-19 pandemic

(2021) Arnaud Fontanet et al.   LANCET

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2

(2021) Alberto A. Amarilla et al.   Frontiers in Microbiology

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

(2021) Nikolaos C. Kyriakidis et al.   npj Vaccines

A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

(2021) Jovin J. Y. Choo et al.   npj Vaccines

Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2

(2021) Chotiwat Seephetdee et al.   Vaccines

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants

(2021) Daniel Martínez-Flores et al.   Frontiers in Immunology

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

(2021) Markus Hoffmann et al.   CELL

Expression and characterization of SARS-CoV-2 spike proteins

(2021) Jeffrey M. Schaub et al.   Nature Protocols

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

(2021) David R. Martinez et al.   Science Translational Medicine

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

(2021) Christopher L. D. McMillan et al.   Science Advances

Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance

(2021) Shi-Yan Ren et al.   World Journal of Clinical Cases

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

(2020) Xiaolong Tian et al.   Emerging Microbes & Infections

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy

(2020) Danilo Licastro et al.   JOURNAL OF VIROLOGY

Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia

(2020) Leon Caly et al.   MEDICAL JOURNAL OF AUSTRALIA

A human neutralizing antibody targets the receptor binding site of SARS-CoV-2

(2020) Rui Shi et al.   NATURE

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

(2020) Dora Pinto et al.   NATURE

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

(2020) Meng Yuan et al.   SCIENCE

Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial

(2020) Angus H. Forster et al.   PLOS MEDICINE

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

(2020) Lihong Liu et al.   NATURE

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

(2020) Ching-Lin Hsieh et al.   SCIENCE

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination

(2020) Ariane Sternberg et al.   LIFE SCIENCES

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana

(2020) Kaewta Rattanapisit et al.   Scientific Reports

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens

(2020) Paco Pino et al.   Processes

Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses

(2019) Hwee-Ing Ng et al.   npj Vaccines

Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays

(2019) David A. Muller et al.   Vaccines

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)

(2018) Germain J.P. Fernando et al.   VACCINE

Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus

(2018) Leah C. Katzelnick et al.   PLoS Neglected Tropical Diseases

Influence of protein fold stability on immunogenicity and its implications for vaccine design

(2017) Sandra Scheiblhofer et al.   Expert Review of Vaccines

High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses

(2017) David A. Muller et al.   Scientific Reports

Microneedle patches for vaccination in developing countries

(2016) Jaya Arya et al.   JOURNAL OF CONTROLLED RELEASE

The success of microneedle-mediated vaccine delivery into skin

(2016) Sarah Marshall et al.   Human Vaccines & Immunotherapeutics

Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses

(2016) David A. Muller et al.   Scientific Reports

Modern Subunit Vaccines: Development, Components, and Research Opportunities

(2013) Peter Michael Moyle et al.   ChemMedChem

Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses

(2012) Germain J.P. Fernando et al.   JOURNAL OF CONTROLLED RELEASE

Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model

(2010) Germain J. P. Fernando et al.   PLoS One

Advances in saponin-based adjuvants

(2009) Hong-Xiang Sun et al.   VACCINE